Rainer Friedrich
Dr. rer. nat., Dipl.-Biochem.
Admissions:
- German Patent Attorney
- European Patent Attorney
- European Trademark Attorney
- European Design Attorney
Dr. Friedrich is authorized to represent clients before the European Patent Office (EPO), the German Patent and Trademark Office (GPTO), the German Federal Patent Court (FPC) as well as the Office of Harmonization for the Internal Market (OHIM).
Practice Areas:
Dr. Friedrich has been active in the field of intellectual property since he joined df-mp in 2004.
Dr. Friedrich’s scientific background in molecular biology, organic chemistry, biochemistry, enzyme kinetics and drug discovery enhances the firm’s large and diversified life sciences practice group.
Dr. Friedrich’s practice focuses on prosecution, opposition and litigation matters concerning German and European patents, with particular emphasis in the pharmaceutical and biotechnology areas.
He has been involved in various multi-national patent disputes regarding patents in the above areas of technology. His practice also includes freedom-to-operate and validity opinions.
Education and Professional Experience:
1993 – 1998
Diploma in biochemistry from the University of Regensburg, Germany (thesis under the supervision of Prof. Luis Moroder, Max Planck Institute for Biochemistry, Martinsried, dealing with the synthesis and biophysical characterization of collagen model peptides)
1999 – 2002
Doctorate degree (summa cum laude) in biochemistry from the Technical University in Munich. He wrote his dissertation in the group of Nobel Prize winner Prof. Robert Huber. Doctoral thesis
2003 – 2004
Postdoctoral fellow at the Max Planck Institute for Biochemistry at Martinsried, Germany
2004 – 2007
Patent attorney candidate at df-mp, trainee at the German Patent Office and the German Federal Patent Court
Since 2007
Patent attorney at df-mp
Publications and Activities:
- Author and co-author of numerous publications:Publications
- Invited speaker at: Gordon Research Conference on Proteolytic Enzymes and their Inhibitors, New London, USA 2004, and General Meeting of the International Proteolysis Society, Nagoya, Japan 2003
